Novo Nordisk is wobbly after new forecast reduction

Danish diet giant Novo Nordisk is once again failing to live up to expectations. The previously successful company has had major problems in the past year as competition has intensified. The share price initially fell 4-5 percent, but quickly turned positive. So far this year, the share is down 50 percent.